HES1 and endometrial cancer: Endometrial cancer studies reveal crosstalk between Notch/Hes1 and Wnt/β-catenin in differentiation: GSK-3β inhibition simultaneously upregulates Hes1 and β-catenin, driving cancer cell proliferation/migration (117).